financetom
Business
financetom
/
Business
/
Rush Enterprises Q4 Earnings, Revenue Decrease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rush Enterprises Q4 Earnings, Revenue Decrease
Feb 18, 2025 2:27 PM

05:00 PM EST, 02/18/2025 (MT Newswires) -- Rush Enterprises ( RUSHA ) reported Q4 earnings Tuesday of $0.91 per diluted share, down from $0.95 a year earlier.

Two analysts polled by FactSet expected $0.84.

Revenue for the quarter ended Dec. 31 was $2.01 billion, down from $2.03 billion a year earlier.

Two analysts surveyed by FactSet expected $1.86 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Corning And AT&T Sign $1 Billion+ Deal To Supercharge Fiber Network
Corning And AT&T Sign $1 Billion+ Deal To Supercharge Fiber Network
Oct 29, 2024
Corning Incorporated ( GLW ) shares are trading higher premarket on Monday after the company inked a multi-year agreement with AT&T Inc. ( T ) . The agreement, which is valued over $1 billion, expands AT&T ( T ) and Corning’s decades-long partnership. The deal entails supplying advanced fiber, cable, and connectivity solutions, supporting AT&T’s fiber network expansion and efforts...
Ford UK employees to strike from Wednesday, union says
Ford UK employees to strike from Wednesday, union says
Oct 29, 2024
Oct 29 (Reuters) - More than a thousand Ford employees in the UK will begin a strike action from Wednesday over pay and contract changes, the Unite union said on Tuesday. (Reporting by Prerna Bedi in Bengaluru; Editing by Varun H K) ...
Monopar Therapeutics Prices Best Efforts Public Offering at $16.25 per Share
Monopar Therapeutics Prices Best Efforts Public Offering at $16.25 per Share
Oct 29, 2024
05:22 AM EDT, 10/29/2024 (MT Newswires) -- Monopar Therapeutics ( MNPR ) said Monday that it priced its best efforts public offering of common shares at $16.25 per share for total proceeds of about $19.2 million. The company expects to close the offering on Wednesday and said proceeds will be used for general working capital. Monopar Therapeutics ( MNPR )...
Goldman Sachs, Morgan Stanley CEOs see more dealmaking in 2025
Goldman Sachs, Morgan Stanley CEOs see more dealmaking in 2025
Oct 29, 2024
LONDON, Oct 29 (Reuters) - The CEOs of Goldman Sachs ( GS ) and Morgan Stanley ( MS ) said on Tuesday they expected corporate dealmaking to pick up in 2025, while the CEO of Apollo Global Management ( APO ) said he expected a presidential victory by Donald Trump would spur more deals. Ted Pick, CEO, Morgan Stanley (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved